|
Volumn 28, Issue 9, 2001, Pages 1319-1325
|
[177Lu-DOTA0,Tyr3]octreotate: Comparison with [111In-DTPA0]octreotide in patients
|
Author keywords
Octreotate; Peptide receptor radiotherapy; Somatostatin; Somatostatin receptor imaging
|
Indexed keywords
1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID;
LUTETIUM;
LUTETIUM 177;
OCTREOTIDE[3 TYROSINE];
PENTETREOTIDE IN 111;
RADIOISOTOPE;
RECEPTOR SUBTYPE;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
UNCLASSIFIED DRUG;
YTTRIUM 90;
(177LUTETIUM DOTA(O)TYR3)OCTREOTATE;
(177LUTETIUM-DOTA(O)TYR3)OCTREOTATE;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
INDIUM;
ORGANOMETALLIC COMPOUND;
PENTETREOTIDE;
RADIOPHARMACEUTICAL AGENT;
SOMATOSTATIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BINDING AFFINITY;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
DRUG PENETRATION;
FEMALE;
HUMAN;
INJECTION;
KIDNEY;
MALE;
NEUROENDOCRINE TUMOR;
RADIATION DOSE DISTRIBUTION;
RADIOACTIVITY;
SPLEEN;
SURVIVAL RATE;
TUMOR REGRESSION;
URINARY EXCRETION;
CHEMISTRY;
COMPARATIVE STUDY;
MIDDLE AGED;
NEOPLASM;
RADIATION DOSE;
SCINTISCANNING;
ADOLESCENT;
ADULT;
AGED;
FEMALE;
HUMANS;
INDIUM RADIOISOTOPES;
LUTETIUM;
MALE;
MIDDLE AGED;
NEOPLASMS;
ORGANOMETALLIC COMPOUNDS;
RADIATION DOSAGE;
RADIOISOTOPES;
RADIOPHARMACEUTICALS;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
|
EID: 17944362339
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/s002590100574 Document Type: Article |
Times cited : (437)
|
References (23)
|